Cargando…
Advanced theranostic materials /
"The present book is covers the recent advances in the development on the regulation of such theragnosis system and their biomedical perspectives to act as a future nanomedicine. Advanced Theranostics Materials is written by a distinguished group of contributors and provides comprehensive cover...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken, New Jersey :
John Wiley & Sons Inc.-Scrivener,
[2015]
|
| Colección: | Advanced materials series (Scrivener Publishing)
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Half Title page
- Title page
- Copyright page
- Preface
- Part 1: System Biology and Translational Medicine
- Chapter 1: Aberrant Signaling Pathways
- 1.1 Cancer
- 1.2 Pathways Deregulated in Cancer: Introduction
- 1.3 Introduction to Nanotechnology
- 1.4 Current Uses in Cancer Diagnostic
- Acknowledgment
- References
- Chapter 2: Application of Nanoparticles in Cancer Treatment
- 2.1 Introduction
- 2.2 Nanoparticles in Cancer Treatment
- 2.3 Nanoparticle Platforms as Drug Delivery Systems for Cancer Therapy
- 2.4 Theranostic Nanomedicine
- 2.5 Selective Drug Delivery and Encapsulation for Chemotherapy
- 2.6 Stimuli-Sensitive Nanopreparations
- 2.7 Multifunctional Nanopreparations
- 2.8 Cancer Nanotechnology: Future and Challenges
- References
- Chapter 3: Biomacromolecule-Gated Mesoporous Silica Drug Delivery Systems for Stimuli-Responsive Controlled Release
- 3.1 Introduction
- 3.2 Protein-Gated MSN Drug Delivery Systems
- 3.3 DNA-Gated MSN Drug Delivery Systems
- 3.4 Conclusions and Perspectives
- Acknowledgments
- References
- Chapter 4: Construction of Functional DNA Nanostructures for Theranostic Applications
- 4.1 The Progress of Structural DNA Nanotechnology
- 4.2 DNA Nanostructures for Diagnostics
- 4.3 DNA Nanostructures for Diagnostics on the Interface
- 4.4 Diagnostic in Homogeneous Solution
- 4.5 DNA Nanostructures for Therapeutics
- 4.6 Integration of Diagnosis and Therapy: Smart DNA Theranostic Nanodevices
- 4.7 Targeted Delivery
- 4.8 Controlled/Triggered Release
- 4.9 Summary and Perspectives
- References
- Part 2: Imaging and Therapeutics
- Chapter 5: Dimercaptosuccinic Acid-Coated Magnetic Nanoparticles as a Localized Delivery System in Cancer Immunotherapy
- 5.1 Introduction
- 5.2 Nanoparticle Detection and Quantification: In Vitro and In Vivo Techniques.
- 5.3 Evaluation of Nanoparticle-Induced Toxicity
- 5.4 Magnetic Targeting of Nanoparticles
- 5.5 A Specific Example: DMSA-Coated Magnetic Nanoparticles
- 5.6 Conclusions
- Acknowledgments
- References
- Chapter 6: Cardiovascular Nanomedicine
- 6.1 Introduction
- 6.2 Nanoscale Cardiovascular Diagnostics
- 6.3 Nanotechnology in Cardiovascular Therapeutics
- 6.4 Nanotechnology in the Surgery of Cardiovascular Disease
- 6.5 Conclusion
- References
- Chapter 7: Chitosan-based Interpenetrating Polymeric Network Systems for Sustained Drug Release
- 7.1 Introduction
- 7.2 IPNs and Their Uses in Drug Delivery
- 7.3 Chitosan
- 7.4 Chitosan-Tamarind Seed Polysaccharide IPN Microparticles and Matrix Tablets for Sustained Release of Aceclofenac
- 7.5 Chitosan-Hydroxyethyl Cellulose IPN Microspheres of Isoniazid
- 7.6 Chitosan-Methyl Cellulose IPN Microspheres of Theophylline
- 7.7 Chitosan-Acrylamide-Grafted-Poly(Vinyl Alcohol) and Hydrolyzed Acrylamide-Grafted-Poly(Vinyl Alcohol) IPN Microgels of Cefadroxil
- 7.8 Chitosan-Poly(N-Isopropylacrylamide) IPN Discs of Diclofenac Sodium
- 7.9 Chitosan-Poly(Ethylene Oxide-Grafted-Acrylamide) Semi-IPN Hydrogel Microspheres of Capecitabine
- 7.10 Acrylamide-Grafted Dextran-Chitosan Semi-IPN Microspheres of Acyclovir
- 7.11 Chitosan-Acrylamide-Grafted Hydroxyethylcellulose Semi-IPN Microspheres of Diclofenac Sodium
- 7.12 Poly [N-Acryloylglycine-Chitosan] IPN Hydrogel of 5-Fluorouracil
- 7.13 Chitosan-N, N2 Dimethylacrylamide Semi-IPN Microspheres of Chlorothiazide
- 7.14 Conclusion
- References
- Chapter 8: Nanocapsules in Biomedicine
- 8.1 Nanocapsules: A Novel Nano-Drug Delivery System
- 8.2 Magic Bullets: Nanocapsules in Future Medicine
- 8.3 In Vitro Applications of Nanocapsules
- 8.4 In Vivo Applications of Nanocapsules
- 8.5 Conclusions
- References.
- Chapter 9: Chitosan-based Polyelectrolyte Complexes
- 9.1 Introduction
- 9.2 Chitosans: Chemical Structure, Physicochemical Properties, and Toxicological and Regulatory Aspects
- 9.3 Polyelectrolyte Complexes: Theoretical Background, Structure, and Basic Properties
- 9.4 Chitosan-based Polyelectrolyte Complexes in Particulate Drug Carriers
- 9.5 Characterization of Chitosan-Based PECs and Chitosan-based PEC Particulate Drug Carriers
- 9.6 Conclusion
- Acknowledgment
- References
- Part 3: Diagnostics and Featured Prognostics
- Chapter 10: Non-invasive Glucose Biosensors Based on Nanomaterials
- 10.1 Diabetes and Its Prevalence
- 10.2 Importance of Glucose Monitoring
- 10.3 Glucose Measurement Methods
- 10.4 Non-invasive Glucose Determination
- 10.5 Glucose Biosensors
- 10.6 New Generation of Non-invasive Glucose Biosensors-Based Nanomaterials
- 10.7 Future Perspective in Glucose Monitoring
- 10.8 Conclusion
- References
- Chapter 11: Self-Directed Assembly of Nanoparticles
- 11.1 Introduction
- 11.2 Self-Assembly through Molecular Interactions/Forces
- 11.3 Hydrogen-Bonding Interactions
- 11.4 Directed Self-Assembly by External Forces
- 11.5 Conclusion
- Acknowledgment
- References
- Index.